Manuel Lopez-Cabrera

Title: Manuel Lopez-Cabrera: Innovator in Pharmaceutical Compositions

Introduction

Manuel Lopez-Cabrera is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize steviosides. His work is aimed at improving treatment options for patients with chronic renal failure.

Latest Patents

Lopez-Cabrera holds a patent for "Pharmaceutical compositions containing steviosides." This invention relates to pharmaceutical compositions that include steviol glycosides and their derivatives. The primary application of this invention is as osmotics, specifically for use in dialysis treatments for chronic renal failure.

Career Highlights

Manuel Lopez-Cabrera is associated with Fresenius Medical Care Deutschland GmbH, a leading company in the healthcare sector. His role at the company allows him to contribute to innovative solutions in medical treatments. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the field.

Collaborations

Lopez-Cabrera has worked alongside notable colleagues such as Abelardo Isaac Aguilera Peralta and Rafael Selgas Gutierrez. Their collaborative efforts have further advanced the research and development of effective pharmaceutical solutions.

Conclusion

Manuel Lopez-Cabrera's contributions to pharmaceutical innovations highlight the importance of research in improving healthcare outcomes. His patent on steviosides demonstrates a commitment to enhancing treatment options for patients with chronic renal failure.